To address the current national emergency, U.S. entities may be eligible to license select Sandia intellectual property at no cost for a limited time. Learn more.

Search/Browse Tech

Microfluidic platform for multiplexed detection in single cells and methods thereof

United States Patent

To discuss licensing opportunities, fill out our Contact Form 
9,957,554
May 1, 2018
View the Complete Patent at the US Patent & Trademark Office
The present invention relates to a microfluidic device and platform configured to conduct multiplexed analysis within the device. In particular, the device allows multiple targets to be detected on a single-cell level. Also provided are methods of performing multiplexed analyses to detect one or more target nucleic acids, proteins, and post-translational modifications.
14/575,886
December 18, 2014
1/1;
C12Q 1/68 (20180101); C40B 30/04 (20060101); B01L 3/00 (20060101);
STATEMENT OF GOVERNMENT INTEREST This invention was made with Government support under contract no. DE-AC04-94AL85000 awarded by the U.S. Department of Energy to Sandia Corporation. The Government has certain rights in the invention.